NO952402L - Substituerte 6-azaandrostenoner - Google Patents
Substituerte 6-azaandrostenonerInfo
- Publication number
- NO952402L NO952402L NO952402A NO952402A NO952402L NO 952402 L NO952402 L NO 952402L NO 952402 A NO952402 A NO 952402A NO 952402 A NO952402 A NO 952402A NO 952402 L NO952402 L NO 952402L
- Authority
- NO
- Norway
- Prior art keywords
- bond
- hydrogen
- lower alkyl
- substituted
- carbon atoms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
- C07C211/41—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C211/44—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
- C07C211/45—Monoamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/14—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/02—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
- C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
- C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/46—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing nine carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pulmonology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US99393092A | 1992-12-18 | 1992-12-18 | |
| US8066593A | 1993-06-18 | 1993-06-18 | |
| PCT/US1993/012419 WO1994014833A2 (fr) | 1992-12-18 | 1993-12-17 | 6-azaandrostenones substituees |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO952402D0 NO952402D0 (no) | 1995-06-16 |
| NO952402L true NO952402L (no) | 1995-08-16 |
Family
ID=26763785
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO952402A NO952402L (no) | 1992-12-18 | 1995-06-16 | Substituerte 6-azaandrostenoner |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP0674651B1 (fr) |
| JP (1) | JPH08504825A (fr) |
| CN (1) | CN1095383A (fr) |
| AP (1) | AP459A (fr) |
| AT (1) | ATE172738T1 (fr) |
| AU (1) | AU673899B2 (fr) |
| BG (1) | BG99729A (fr) |
| CA (1) | CA2152053A1 (fr) |
| CZ (1) | CZ157695A3 (fr) |
| DE (1) | DE69321849D1 (fr) |
| FI (1) | FI953009A (fr) |
| HU (1) | HUT72083A (fr) |
| IL (1) | IL108073A0 (fr) |
| IS (1) | IS4106A (fr) |
| LV (1) | LV10958B (fr) |
| MX (1) | MX9308015A (fr) |
| NO (1) | NO952402L (fr) |
| NZ (1) | NZ261415A (fr) |
| OA (1) | OA10167A (fr) |
| PL (1) | PL314532A1 (fr) |
| SI (1) | SI9300665A (fr) |
| SK (1) | SK79495A3 (fr) |
| TW (1) | TW293824B (fr) |
| WO (1) | WO1994014833A2 (fr) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW369521B (en) * | 1993-09-17 | 1999-09-11 | Smithkline Beecham Corp | Androstenone derivative |
| US5516779A (en) * | 1994-06-08 | 1996-05-14 | Merck & Co., Inc. | 17β-substituted-6-azasteroid derivatives useful as 5α-reductase inhibitors |
| US5817818A (en) * | 1994-09-16 | 1998-10-06 | Glaxo Wellcome Inc. | Androstenones |
| US5541322A (en) * | 1994-10-14 | 1996-07-30 | Glaxo Wellcome Inc. | Synthesis of 6-azaandrostenones |
| US5543417A (en) * | 1994-10-21 | 1996-08-06 | Merck & Co., Inc. | Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents |
| US5595996A (en) * | 1994-10-25 | 1997-01-21 | Merck & Co., Inc. | 7-substituted 4-aza cholanic acid derivatives and their use |
| GB9506678D0 (en) * | 1995-03-31 | 1995-05-24 | Glaxo Inc | Substituted 6-azacholesten-3-ones |
| AU704933B2 (en) * | 1995-10-19 | 1999-05-06 | Merck & Co., Inc. | 16-substituted-6-aza-steroid 5-alpha-reductase inhibitors |
| US5935968A (en) * | 1997-03-17 | 1999-08-10 | Merck & Co., Inc. | Methods for treating polycystic ovary syndrome |
| EP1615866B1 (fr) | 2003-04-15 | 2011-02-16 | Aquinox Pharmaceuticals Inc. | Derives d'indene utilises en tant qu'agents pharmaceutiques |
| US7790770B2 (en) | 2005-11-23 | 2010-09-07 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
| EP2970100A1 (fr) | 2013-03-14 | 2016-01-20 | Aquinox Pharmaceuticals (Canada) Inc. | Modulateurs de ship1 et méthodes associées |
| US9765085B2 (en) | 2013-03-14 | 2017-09-19 | Aquinox Pharmaceuticals (Canada) Inc. | SHIP1 modulators and methods related thereto |
| CA2986790A1 (fr) | 2015-06-26 | 2016-12-29 | Aquinox Pharmaceuticals (Canada) Inc. | Formes solides cristallines du sel d'acetate de (1s,3s,4r)-4-((3as,4r,5s,7as)-4-(aminomethyl)-7a-methyl-1-methyleneoctahydro-1h-inden-5-yl)-3-(hydroxymethyl)-4-methylcyclohexanol |
| AU2017209430A1 (en) | 2016-01-20 | 2018-07-12 | Aquinox Pharmaceuticals (Canada) Inc. | Synthesis of a substituted indene derivative |
| BR112018072255B1 (pt) * | 2016-04-29 | 2024-02-06 | The Research Foundation For The State University Of New York | Azasteroides para tratamento de tuberculose |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE165368T1 (de) * | 1991-12-20 | 1998-05-15 | Glaxo Wellcome Inc | Inhibitoren von testosteron-5-alpha reductase. |
| US5438061A (en) * | 1993-07-16 | 1995-08-01 | Merck & Co., Inc. | 7-substituted-δ4-6-azasteroid derivatives as 5α-reductase inhibitors |
-
1993
- 1993-12-13 AP APAP/P/1993/000599A patent/AP459A/en active
- 1993-12-15 TW TW082110624A patent/TW293824B/zh active
- 1993-12-15 MX MX9308015A patent/MX9308015A/es unknown
- 1993-12-15 IS IS4106A patent/IS4106A/is unknown
- 1993-12-17 IL IL10807393A patent/IL108073A0/xx unknown
- 1993-12-17 JP JP6515375A patent/JPH08504825A/ja active Pending
- 1993-12-17 HU HU9501775A patent/HUT72083A/hu unknown
- 1993-12-17 PL PL93314532A patent/PL314532A1/xx unknown
- 1993-12-17 AT AT94906449T patent/ATE172738T1/de not_active IP Right Cessation
- 1993-12-17 SI SI9300665A patent/SI9300665A/sl unknown
- 1993-12-17 AU AU60150/94A patent/AU673899B2/en not_active Ceased
- 1993-12-17 EP EP94906449A patent/EP0674651B1/fr not_active Expired - Lifetime
- 1993-12-17 NZ NZ261415A patent/NZ261415A/en unknown
- 1993-12-17 CZ CZ951576A patent/CZ157695A3/cs unknown
- 1993-12-17 CA CA002152053A patent/CA2152053A1/fr not_active Abandoned
- 1993-12-17 WO PCT/US1993/012419 patent/WO1994014833A2/fr active IP Right Grant
- 1993-12-17 SK SK794-95A patent/SK79495A3/sk unknown
- 1993-12-17 DE DE69321849T patent/DE69321849D1/de not_active Expired - Lifetime
- 1993-12-18 CN CN93119914A patent/CN1095383A/zh active Pending
-
1995
- 1995-06-14 OA OA60676A patent/OA10167A/en unknown
- 1995-06-16 FI FI953009A patent/FI953009A/fi unknown
- 1995-06-16 NO NO952402A patent/NO952402L/no unknown
- 1995-06-16 LV LVP-95-179A patent/LV10958B/en unknown
- 1995-06-19 BG BG99729A patent/BG99729A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU6015094A (en) | 1994-07-19 |
| EP0674651A1 (fr) | 1995-10-04 |
| LV10958A (lv) | 1995-12-20 |
| HU9501775D0 (en) | 1995-08-28 |
| AU673899B2 (en) | 1996-11-28 |
| NZ261415A (en) | 1997-03-24 |
| PL314532A1 (en) | 1996-09-16 |
| BG99729A (en) | 1996-01-31 |
| CZ157695A3 (en) | 1995-12-13 |
| IS4106A (is) | 1994-06-19 |
| EP0674651B1 (fr) | 1998-10-28 |
| IL108073A0 (en) | 1994-04-12 |
| FI953009A (fi) | 1995-08-15 |
| CN1095383A (zh) | 1994-11-23 |
| WO1994014833A3 (fr) | 1994-09-29 |
| NO952402D0 (no) | 1995-06-16 |
| TW293824B (fr) | 1996-12-21 |
| MX9308015A (es) | 1994-08-31 |
| FI953009A0 (fi) | 1995-06-16 |
| WO1994014833A2 (fr) | 1994-07-07 |
| JPH08504825A (ja) | 1996-05-28 |
| AP459A (en) | 1996-02-14 |
| AP9300599A0 (en) | 1994-01-31 |
| LV10958B (en) | 1996-10-20 |
| ATE172738T1 (de) | 1998-11-15 |
| DE69321849D1 (de) | 1998-12-03 |
| CA2152053A1 (fr) | 1994-07-07 |
| HUT72083A (en) | 1996-03-28 |
| SI9300665A (en) | 1994-06-30 |
| OA10167A (en) | 1996-12-18 |
| SK79495A3 (en) | 1995-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO952402L (no) | Substituerte 6-azaandrostenoner | |
| SE9302080D0 (sv) | New compounds | |
| NO904904L (no) | Fremgangsmaate for fremstilling av en polypeptidforbindelse | |
| DE69227088D1 (de) | Verwendung von 1-(aminoalkyl)-3-Quinoxalin-2-on Derivaten zur Herstellung von neuroprotektiven Mitteln | |
| DK132188D0 (da) | Anvendelse af tetrahydrobenz(c,d)indol-6-carboxamider som anxiolytika | |
| AU2868689A (en) | Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia | |
| ATE121385T1 (de) | Harnstoffderivate, ihre herstellung und ihre verwendung bei der therapie. | |
| HU894019D0 (en) | Process for producing condensed pyrazole-3-oxo-propiononitryl derivatives and pharmaceutical preparatives containing them | |
| NO881835D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive bicykliske forbindelser. | |
| DE3770321D1 (de) | 1,5-benzothiazepinderivate, deren herstellung und deren verwendung in der therapie. | |
| DE3876711D1 (de) | Piperidin-derivate, deren herstellung und deren verwendung als heilmittel. | |
| HUT65453A (en) | Process for producing 6-oxo-azepinoindole derivatives and pharmaceutical preparations containing them | |
| EP0230020A3 (en) | 1,2,3,4,4a,9b-hexahydro-4a-aminoalkyldibenzofurans, a process for their preparation and their use as medicaments | |
| NO164170C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzhydryl-4-cinnamyl-piperazinderivater. | |
| ES2001893A6 (es) | Procedimiento para la obtencion de derivados de metilendioxifenantreno | |
| AU2013888A (en) | Uricosuric composition | |
| SE8802162L (sv) | Nya aminoacylater av glycerolacetal | |
| DE3766236D1 (de) | Dibenzo(be)oxepinessigsaeure-derivate, deren herstellung und therapeutische verwendung. | |
| MY101746A (en) | 1,5-benzothiazepine derivatives, a process for preparing the same, pharmaceutical compositions as well as the use thereof. | |
| WO1989005809A1 (fr) | Composes d'imidazoquinoline et de pyrimidoquinoline, naphtyridine et de pyridopyrazine | |
| MY103509A (en) | Indole derivatives. | |
| RU94031211A (ru) | Производные изатина, способ их получения и фармацевтическая композиция на их основе |